Staphylococcus aureus and Staphylococcus epidermidis are major human pathogens of increasing importance due to the dissemination of antibiotic-resistant strains. Evidence suggests that the ability to form matrixencased biofilms contributes to the pathogenesis of S. aureus and S. epidermidis. In this study, we investigated the functions of two staphylococcal biofilm matrix polymers: poly-N-acetylglucosamine surface polysaccharide (PNAG) and extracellular DNA (ecDNA). We measured the ability of a PNAG-degrading enzyme (dispersin B) and DNase I to inhibit biofilm formation, detach preformed biofilms, and sensitize biofilms to killing by the cationic detergent cetylpyridinium chloride (CPC) in a 96-well microtiter plate assay. When added to growth medium, both dispersin B and DNase I inhibited biofilm formation by both S. aureus and S. epidermidis. Dispersin B detached preformed S. epidermidis biofilms but not S. aureus biofilms, whereas DNase I detached S. aureus biofilms but not S. epidermidis biofilms. Similarly, dispersin B sensitized S. epidermidis biofilms to CPC killing, whereas DNase I sensitized S. aureus biofilms to CPC killing. We concluded that PNAG and ecDNA play fundamentally different structural roles in S. aureus and S. epidermidis biofilms.
Staphylococcus aureus and Staphylococcus epidermidis are among the most common bacteria isolated from human infections. S. aureus colonizes mucosal surfaces such as the anterior nares, whereas S. epidermidis is part of the normal microflora of the skin. Infection results when a breach in the mucosal barrier or skin allows bacterial cells access to the underlying tissues or to the bloodstream (36, 39) . S. aureus causes numerous infections, ranging from acute skin abscesses to life-threatening bacteremias and endocarditis (36) . S. epidermidis is a leading cause of infections associated with implanted medical devices (56) . The increasing incidence of antibiotic-resistant strains of S. aureus and S. epidermidis has heightened efforts to find new ways to fight these pathogens (6, 52) .
Both S. aureus and S. epidermidis are known for their ability to form biofilms, which are defined as communities of bacteria, encased in a self-synthesized extracellular polymeric matrix, growing attached to a biotic or abiotic surface (15, 19, 42) . Biofilms that form on tissues or medical devices are extremely difficult to eradicate because the biofilm mode of growth protects bacterial cells from killing by antibiotics and host defenses (18) . Evidence suggests that biofilm formation plays a role in S. aureus wound infections (2) and osteomyelitis (7) and in S. epidermidis catheter infections (10) .
Numerous studies have identified and characterized extracellular factors that mediate surface attachment and intercellular adhesion in S. aureus and S. epidermidis biofilms. Both species produce poly-␤(1,6)-N-acetyl-D-glucosamine (PNAG), a surface polysaccharide that is sometimes referred to as polysaccharide intercellular adhesin (11, 37) . PNAG contributes to biofilm accumulation and immune evasion in both S. aureus and S. epidermidis (10, 35, 57) . However, not all strains produce PNAG, and many PNAG-deficient strains exhibit a strong biofilm phenotype (42, 48, 54) . Recently, extracellular DNA (ecDNA) has also been shown to comprise a structural component of the S. aureus and S. epidermidis biofilm matrix (13, 46, 47) . In addition, proteinaceous adhesins, such as S. aureus biofilm-associated protein (12) and S. epidermidis accumulation-associated protein (24) , as well as cell wall teichoic acids (20, 50, 55) , have been shown to participate in surface attachment and biofilm cohesion.
The purpose of the present study was to gain better insight into the functional roles of PNAG and ecDNA in S. aureus and S. epidermidis biofilms. By treating biofilms grown in 96-well microtiter plates with a PNAG-degrading enzyme (dispersin B) and DNase I, we obtained evidence that PNAG and ecDNA perform markedly different functions in S. aureus and S. epidermidis biofilms.
TSB containing 20 g/ml of dispersin B or 100 g/ml of DNase I. Aliquots of cells (200 l each) were transferred to the wells of a 96-well tissue-culturetreated polystyrene microtiter plate (Falcon no. 324662; Becton-Dickinson), and the plate was incubated for 24 h. Biofilms were washed once with water and then dried. Biofilms were stained for 1 min with 200 l of Gram's crystal violet and then rinsed with water and dried. The amount of biofilm biomass was quantitated by destaining the biofilms for 10 min with 33% acetic acid (by vol) and then measuring the absorbance of the crystal violet solution at 590 nm (A 590 ).
Biofilm detachment assay. Biofilms were grown in 96-well microtiter plates as described above. Biofilms were rinsed once with water and then treated with 200 l of dispersin B (20 g/ml in PBS), DNase I (100 g/ml in 150 mM NaCl, 1 mM CaCl 2 ), or various restriction endonucleases (20 U/ml in 10 mM Tris [pH 7.9], 10 mM MgCl 2 , 50 mM NaCl, 1 mM dithiothreitol). Control wells were treated with 200 l of the appropriate buffer alone. After 1 h at 37°C, biofilms were rinsed with water and stained with crystal violet as described above.
Biofilm killing assay. Biofilms were grown in 96-well microtiter plates as described above. Biofilms were rinsed once with water and then treated with 200 l of TSB containing 20 g/ml of dispersin B or 100 g/ml of DNase I. Control wells were treated with 200 l of TSB alone. Control experiments indicated that dispersin B and DNase I did not affect S. aureus or S. epidermidis growth and viability (data not shown). After 10 min at 37°C, 20 l of 3% CPC (for S. aureus) or 1% CPC (for S. epidermidis) was added to each well and biofilms were incubated for 5 min at room temperature. Control wells received 20 l of water. For biofilms treated with TSB alone and for S. aureus biofilms treated with dispersin B and S. epidermidis biofilms treated with DNase I, biofilms were washed four times with PBS to remove the CPC and then treated with 100 g/ml of DNase I (for S. aureus) or 20 g/ml of dispersin B (for S. epidermidis) to dissolve the biofilm. These reactions were carried out in the enzyme buffers described above. After 10 min, cells were mixed and then serial dilutions were plated on agar. For S. aureus biofilms treated with DNase I and S. epidermidis biofilms treated with dispersin B, cells were mixed and then a 50-l aliquot of cells was diluted in 50 ml of PBS. The cells were passed through an analytical test filter funnel (no. 145-2020; Nalgene, Rochester, NY), and the filter was rinsed with 250 ml of sterile water, aseptically removed from the filter unit, and placed on a blood agar plate. Colonies were enumerated after 24 h.
Planktonic cell killing assay. Cells scraped from an agar plate were resuspended in PBS and filtered as described above. Cells were adjusted to 1 ϫ 10 7 to 5 ϫ 10 7 CFU/ml and transferred in 180-l aliquots to the wells of a 96-well microtiter plate. Twenty microliters of 0.0025 to 0.01% CPC was transferred to each well. Control wells received 20 l of water. After 5 min at room temperature, cells were diluted and plated on agar. In some experiments, planktonic cells were pretreated for 15 min with 20 g/ml of dispersin B prior to the addition of CPC. Total hexosamine assay. Tissue-culture-treated polystyrene petri dishes (100-mm-diameter; Falcon no. 353003) were filled with 20 ml of TSB containing 10 4 to 10 5 CFU/ml and incubated for 24 h. The resulting biofilms were rinsed with PBS and scraped into a small volume of PBS. Aliquots of cells (Ϸ60 mg [wet weight]) were transferred to 1.5-ml polypropylene microcentrifuge tubes and resuspended in 400 l of 20 g/ml dispersin B in PBS. Control cells were resuspended in PBS alone. After 1 h at 37°C, cells were pelleted and the amount of total hexosamine in the supernatant was measured by using the Morgan-Elson assay as previously described (53) .
Statistics and reproducibility of results. Biofilm inhibition and killing assays and biofilm detachment assays with dispersin B and DNase I were performed in duplicate wells. Biofilm detachment assays with restriction endonucleases were performed in quadruplicate wells. Replicate wells exhibited 0 to 10% variation in A 590 or CFU/well values. The significance of differences between means was calculated using a Student t test. P values of Ͻ5% were considered significant. All inhibition and detachment assays were performed on at least three occasions with similarly significant decreases in A 590 values. Total hexosamine assays were performed on at least two occasions with similar increases in total hexosamine release. Killing assays were performed on numerous occasions with similar highly significant decreases in CFU/well values. Figure 1A shows S. aureus and S. epidermidis biofilm formation in the wells of a 96-well microtiter plate. Biofilms were stained with crystal violet, which stains bacterial cells and biofilm matrix components but not polystyrene (43) . The amount of biofilm biomass was measured by destaining the biofilms and quantitating the amount of bound dye (Fig.  1B) . Biofilm formation by S. aureus strain SH1000 and by S. epidermidis strains NJ9709 and 1457 was significantly inhibited in growth medium supplemented with dispersin B compared to biofilm formation in unsupplemented medium. These results are consistent with those of previous studies showing that dispersin B inhibited biofilm formation by 18 out of 18 S. aureus strains and 26 out of 26 PNAG-positive S. epidermidis strains isolated from prosthetic joint infections (48) and by S. epidermidis strain 1457 (25) . Biofilm formation by S. aureus strain MRSA252, which produced weaker biofilms than strain SH1000, was not significantly inhibited by dispersin B.
RESULTS

Inhibition of biofilm formation by the PNAG-degrading enzyme dispersin B.
Detachment of preformed biofilms by dispersin B. Fig. 1C and D show 24-h-old S. aureus and S. epidermidis biofilms treated with dispersin B. Dispersin B had no significant effect on the attachment of S. aureus SH1000 and MRSA252 biofilms. In contrast, dispersin B rapidly and efficiently detached S. epidermidis NJ9709 and 1457 biofilms. These findings are consistent with those of previous studies demonstrating that dispersin B detached biofilms produced by various strains of S. epidermidis (9, 25, 32) but not biofilms produced by S. aureus strain 383 (9) .
PNAG is not a major matrix component in S. aureus biofilms. The amount of PNAG present in S. aureus and S. epidermidis biofilms was measured by treating biofilm cells with dispersin B and then quantitating the amount of total hexosamine in the cell supernatant using the Morgan-Elson assay (Fig. 2) . Four different S. aureus strains did not release detectable amounts of total hexosamine when treated with dispersin B, whereas S. epidermidis strains NJ9709 and 1457 exhibited large increases in the amount of total hexosamine in the cell supernatant. To rule out the possibility that dispersin B does not penetrate aggregates of S. aureus biofilm cells, we pretreated the cells with DNase I, which disaggregates the cells (see below), prior to treating them with dispersin B. S. aureus biofilm cells treated in this manner still did not release detectable amounts of total hexosamine after dispersin B treatment (data not shown).
PNAG protects S. epidermidis biofilm cells from detergent killing. Previous studies showed that dispersin B sensitizes biofilms produced by the gram-negative bacterium Aggregatibacter actinomycetemcomitans to killing by the cationic detergent CPC (27) . We tested whether dispersin B could also sensitize S. aureus SH1000 and S. epidermidis NJ9709 biofilms to CPC killing. Control experiments indicated that the minimal bactericidal concentration (Ͼ99.999% killing in 5 min) of CPC was 0.0003% against S. aureus SH1000 planktonic cells and 0.001% against S. epidermidis NJ9709 planktonic cells and that S. aureus SH1000 and S. epidermidis NJ9709 biofilms were resistant to killing by CPC concentrations that were 1,000-fold and 100-fold greater, respectively, than their planktonic minimal bactericidal concentrations (data not shown).
Pretreatment of S. aureus SH1000 biofilms with dispersin B did not increase their sensitivity to killing by 0.3% CPC in 5 min (Fig. 3A) . In contrast, pretreatment of S. epidermidis NJ9709 biofilms with dispersin B resulted in a 5-to 6-log unit decrease in CFU/well values after treatment with 0.1% CPC for 5 min compared to values for control biofilms that were pretreated with PBS alone. Time course studies showed that killing of dispersin B-treated S. epidermidis biofilms by CPC VOL. 74, 2008 STAPHYLOCOCCAL BIOFILM POLYMERS 471 was complete within 1 min (Fig. 3B) . Pretreatment of S. epidermidis planktonic cells with dispersin B did not increase their susceptibility to killing by CPC (Fig. 3C ), indicating that PNAG protects S. epidermidis cells from CPC killing at the multicellular level. Inhibition of biofilm formation by DNase I. Figure 4A and B show that biofilm formation by S. aureus strains SH1000 and MRSA252 and by S. epidermidis strain 1457 was significantly inhibited in medium supplemented with DNase I. These findings are consistent with those of previous studies demonstrating that DNase I inhibits biofilm formation by two different S. aureus clinical isolates (13, 47) and six different S. epidermidis reference strains and clinical isolates (46) .
Detachment of biofilms by DNase I. Figure 4C and D show 24-h-old S. aureus and S. epidermidis biofilms treated for 1 h with DNase I. DNase I caused significant detachment of S. aureus biofilms from the surface. Microscopic analysis indicated that DNase I rapidly dispersed S. aureus biofilms into uniform suspensions of small cell clusters which did not dis- perse into single cells upon extended incubation (data not shown). DNase I did not cause significant detachment of biofilms produced by S. epidermidis 1457 or NJ9709. These findings are consistent with those of previous studies demonstrating that mature biofilms produced by six different S. epidermidis reference strains and clinical isolates were resistant to detachment by DNase I (46). To confirm that ecDNA comprises a structural component of the S. epidermidis biofilm matrix, we treated S. epidermidis NJ9709 biofilms with DNase I and then with a 1% solution of the anionic detergent SDS (Fig. 5) . Previous studies showed that Pseudomonas aeruginosa biofilms pretreated with DNase I were sensitized to detachment by SDS (3). DNase I pretreatment did not sensitize S. epidermidis biofilms to SDS detachment. However, SDS caused DNase I-treated S. epidermidis biofilms to condense into long bundles of thick fibrils that covered the entire surface of the well (Fig. 5) . Neither DNase I nor SDS had any effect on the viability of S. epidermidis cells under these conditions (data not shown).
Detachment of S. aureus biofilms by restriction endonucleases. We tested the ability of various restriction endonucleases to detach S. aureus SH1000 biofilms (Fig. 6A) . The amount of biofilm detachment depended on the frequency of the enzyme recognition sequence in the S. aureus genome (Fig. 6A) . Enzymes that produced restriction fragments with an average size of Ͻ10 kb caused efficient biofilm detachment, whereas enzymes that produced restriction fragments with an average size of 11 to 24 kb caused partial detachment. These findings suggest that the fraction of S. aureus ecDNA that mediates intercellular adhesion is composed primarily of genomic DNA. Biofilms produced by three other S. aureus strains (MZ100, MSRA252, and 8325) exhibited similar detachment phenotypes when treated with HinfI (average restriction fragment size, 0.4 kb) or BamHI (average restriction fragment size, 23.9 kb) (Fig. 6B) .
ecDNA protects S. aureus biofilm cells from detergent killing. We tested the ability of DNase I to render S. aureus SH1000 and S. epidermidis NJ9709 biofilm cells sensitive to killing by CPC (Fig. 7) . Pretreatment of S. aureus SH1000 biofilms with DNase I resulted in a 4-log-unit decrease in CFU/well values after treatment with 0.3% CPC for 5 min compared to results for control biofilms that were pretreated with DNase I buffer alone. DNase I had an identical effect on killing of S. aureus MRSA252 and 8325 biofilm cells by CPC (data not shown). DNase I did not sensitize S. epidermidis NJ9709 biofilms to killing by 0.01% CPC in 5 min (Fig. 7) .
DISCUSSION
Biochemical studies have confirmed that PNAG is produced by both S. aureus and S. epidermidis (29, 37) . Homologues of the icaADBC locus, which encodes the production of PNAG in S. aureus and S. epidermidis, have been identified in various other staphylococci, including S. caprae, S. capitis, S. cohnii, S. lugdunensis, S. pasteuri, and S. saprophyticus (4, 16, 17, 40) . However, PNAG production has not been directly demonstrated in these species. A polysaccharide that is nearly identical to staphylococcal PNAG is produced by various gram-negative Proteobacteria, including Escherichia coli, Pseudomonas fluorescens, Yersinia pestis, Actinobacillus pleuropneumoniae, Aggregatibacter (Actinobacillus) actinomycetemcomitans, and Bordetella spp. (25, 33, 44) . Functions ascribed to proteobacterial PNAG include abiotic surface attachment, intercellular adhesion, biofilm formation, detergent resistance, antibiotic resistance, and epithelial cell attachment (1, (25) (26) (27) 45) .
Several observations suggest that PNAG performs different functions in S. aureus and S. epidermidis biofilms. For example, S. aureus PNAG mutants can still form biofilms in vitro and in vivo, whereas S. epidermidis PNAG mutants exhibit a severely reduced biofilm phenotype (5, 21) . Also, nearly all strains of S. aureus carry the icaADBC locus (42), whereas ica genes are absent in up to half of S. epidermidis strains isolated from device-associated infections (8) and in nearly all skin and mucosal isolates (58) . In addition, S. epidermidis mutant strains deficient in PNAG production exhibit decreased virulence in animal models of both systemic and device-associated infection, whereas S. aureus PNAG-deficient strains exhibit reduced virulence in animal models of systemic but not device-associated infection (34, 35, 49) . In the present study, we showed that the PNAG-degrading enzyme dispersin B was able to detach preformed biofilms produced by S. epidermidis and render them sensitive to detergent killing whereas dispersin B had no effect on the attachment of preformed S. aureus biofilms or their sensitivity to detergent killing ( Fig. 1C and 3) . In addition, only small quantities of hexosamine were released from S. aureus biofilms treated with dispersin B compared to the amount released by S. epidermidis biofilms (Fig. 2) . Taken together, these findings suggest that PNAG is a major matrix adhesin in S. epidermidis biofilms and a minor component of S. aureus biofilms. The role of PNAG in S. aureus biofilms may be similar to its role in S. lugdunensis biofilms, which are also resistant to detachment by dispersin B (17) . When added to the culture medium at the time of inoculation, dispersin B inhibited biofilm formation by S. aureus strain SH1000 (Fig. 1A) . The fact that mature S. aureus biofilms were resistant to detachment by dispersin B suggests that PNAG may function in the early stages of S. aureus biofilm development.
In the present study, we also examined the role of ecDNA in S. aureus and S. epidermidis biofilm formation. Our data confirm that ecDNA is a structural component of the biofilm matrix in both species (Fig. 4 and 5) (13, 46, 47) . However, our findings suggest that ecDNA is a major structural component in the S. aureus biofilm matrix and a minor structural component in the S. epidermidis biofilm matrix. This hypothesis is based on the fact that DNase I inhibited S. aureus biofilm formation, detached preformed S. aureus biofilms, and rendered preformed S. aureus biofilms sensitive to detergent killing whereas DNase I had no effect on S. epidermidis biofilm formation, attachment, or detergent sensitivity (Fig. 4 and 7) . Previous studies showed that S. aureus ecDNA may be comprised of genomic DNA released from lysed biofilm cells (47) . Consistent with this hypothesis, we found that the ability of various restriction endonucleases to detach preformed S. aureus biofilms depended on the frequency of their recognition sequence in the S. aureus genome (Fig. 6 ). The results of these studies suggest that S. aureus ecDNA fragments of Ͼ11 kb in size can function as intercellular adhesins. Interestingly, we found that micrococcal nuclease rapidly and efficiently detached S. aureus biofilms (unpublished data), suggesting that this enzyme may play a role in biofilm cell detachment and biofilm dispersal. Our findings indicate that depolymerization of either S. aureus ecDNA or S. epidermidis PNAG sensitizes the respective biofilm cells to killing by the cationic detergent CPC (Fig. 3 and 7) . Previous studies showed that depolymerization of PNAG sensitizes A. actinomycetemcomitans biofilm cells to killing by the anionic detergent SDS (28) . In all cases, detergent sensitivity is associated with dissolution and detachment of the biofilm cells. Taken together, these findings suggest that matrix polymers such as ecDNA and PNAG can act as general diffusion barriers that prevent access of detergents to the biofilm cells. However, previous studies also showed that exogenously added S. epidermidis PNAG can interfere with the antimicrobial activity of glycopeptide antibiotics, including vancomycin and teicoplanin (14) . These findings suggest that PNAG may also form physical complexes with some antimicrobial agents, thereby sequestering the agents within the polymeric matrix. 
